Parabilis Medicines, a clinical-stage biopharmaceutical company committed to creating extraordinary medicines for people living with cancer, today announced the presentations of trial-in-progress posters on the Company’s first-in-human clinical trial evaluating…
Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology, today presented new translational data at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting. The study demonstrates that botensilimab-based therapy…
The “United States Vaccines Market Size, Top 47 Vaccines Brand In-depth Analysis, Insights, and Forecasts to 2033” report has been added to ResearchAndMarkets.com’s offering. The United States vaccines market size was valued at USD…
TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (the “Company”), an oncology company integrating novel delivery technology with standard of care therapies and its investigational immunotherapeutic to transform treatment for patients with…
Quadria Capital, Asia’s premier healthcare-focused private equity firm, today announced the final close of its Fund III with US$1.07 billion in total commitments, significantly exceeding its original $800 million target.…
AriBio and Fujirebio Reach Key Milestone in Alzheimer’s Biomarker Research with Completion of Sample Collection from Phase 3 Trial Fujirebio Holdings Inc., along with its wholly owned subsidiary Fujirebio Diagnostics,…
CVS Pharmacy: Bringing Personalized Care to Communities with New Small Format Stores In a rapidly evolving health care landscape, one thing remains constant: the importance of trusted, accessible, and personalized…
Vasomune Therapeutics to Present Late-Breaking Research on AV-001 at the 2025 American Thoracic Society International Conference Vasomune Therapeutics Inc., a clinical-stage biopharmaceutical company developing novel therapeutics to address diseases driven…
Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) reported robust financial and operational results for the first quarter of 2025, underscoring the company’s continued momentum and strategic focus on advancing its late-stage…
Twist Bioscience Spins Out DNA Data Storage Platform into New Independent Company, Atlas Data Storage Twist Bioscience Corporation (NASDAQ: TWST), a leading and innovative company operating in the mid-cap growth…
Henry Schein Reports Strong First Quarter 2025 Financial Results, Reaffirms Full-Year Guidance Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of healthcare solutions for office-based dental and medical practitioners,…
ImmunityBio Requests Urgent FDA Meeting After Refusal to File sBLA for ANKTIVA in NMIBC Papillary Disease, Citing Sudden Reversal from January Guidance ImmunityBio, Inc. (NASDAQ: IBRX), a clinical-stage immunotherapy company…